Explore the words cloud of the REGENERA project. It provides you a very rough idea of what is the project "REGENERA" about.
The following table provides information about the project.
|Coordinator Country||Italy [IT]|
|Total cost||2˙698˙813 €|
|EC max contribution||1˙889˙169 € (70%)|
1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
|Duration (year-month-day)||from 2018-06-01 to 2020-05-31|
Take a look of project's partnership.
Tensive was founded in 2012 to address the challenge of developing better biomaterials for regenerative medicine. We developed a bio absorbable scaffold based on highly biocompatible polyurethaneester. Our patented scaffolds provide a synthetic micro-vascular network that enables adipocytes colonization in vivo. This unique design leads to vascularization, fat integration and volume maintaining after implantation. Based on these unique properties, we will bring to the market REGENERA, an innovative mammary prosthesis that is degraded over time and replaced by the patient´s fat. Silicone implants, the most currently used breast tissue modifications, have important risks and need replacement every 10-15 years. Fat grafting, the best alternative nowadays, has been linked to carcinogenic risks and does not promote vascularization (leading to necrosis) with multiple interventions needed for large reconstructions. REGENERA, which only requires one surgical intervention, will meet the need to develop biomaterials able to promote new blood vessels formation that perpetuate the reconstructed tissue. REGENERA will have a significant impact on various levels: (i) Healthcare system: it will save the cost of additional surgeries (more than €241M yearly in the EU), helping to the sustainability of the Healthcare system. (ii) breast cancer patients: it will offer a solution to lumpectomy patients, for whom there are no good solutions yet; a better alternative for mastectomy and breast augmentation patients; a permanent solution by a single surgery for all patients, improving their quality of life. (iii) company: it will increase Tensive’s revenues (cumulative profit of €257M with a ROI of 19.37 by 2025) (iv) society: it will highly benefit 230,000 women needing reconstructive surgery after breast cancer, together with the 1.35M women undergoing breast augmentation for personal reasons
|Web page of the project||Documents, reports||2019-10-01 09:19:20|
Take a look to the deliverables list in detail: detailed list of REGENERA deliverables.
|year||authors and title||journal||last update|
Eleonora Rossi, Julien Guerrero, Paola Aprile, Alessandro Tocchio, Elisabeth A. Kappos, Irini Gerges, Cristina Lenardi, Ivan Martin, Arnaud Scherberich
Decoration of RGD-mimetic porous scaffolds with engineered and devitalized extracellular matrix for adipose tissue regeneration
published pages: 154-166, ISSN: 1742-7061, DOI: 10.1016/j.actbio.2018.04.039
|Acta Biomaterialia 73||2019-08-30|
Irini Gerges, Margherita Tamplenizza, Federico Martello, Camilla Recordati, Cristina Martelli, Luisa Ottobrini, Mariacaterina Tamplenizza, Scott A. Guelcher, Alessandro Tocchio, Cristina Lenardi
Exploring the potential of polyurethane-based soft foam as cell-free scaffold for soft tissue regeneration
published pages: 141-153, ISSN: 1742-7061, DOI: 10.1016/j.actbio.2018.04.011
|Acta Biomaterialia 73||2019-08-30|
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "REGENERA" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "REGENERA" are provided by the European Opendata Portal: CORDIS opendata.
First in the world ecological and sustainable cream for wound care, based on microalgaprasinococcus capsulatusRead More
NATURE FRIENDLY WATER HYDRAULIC STEERING SYSTEMRead More
MCBD (MULTI-CORE BIOPSY DEVICE) INNOVATIVE BIOPSY TECHNOLOGY FOR THE NEW ERA OF TARGETED MEDICINERead More